Laura Schioppa (Pharmacognosy (GNOS/LDRI) research group: “Study of the potential of triterpenic esters and derivatives as antiparasitic agents” Alexandra Degraeve (Integrated PharmacoMetrics, PharmacoGenomics and PharmacoKinetics (PMGK/LDRI) and Metabolism and Nutrition (MNUT/LDRI) research groups): “Tacrolimus and gut microbiota : investigation of bidirectional interactions” info: G.

Medication review to prevent avoidable hospital admissions in older people with multi-morbidity: Measuring outcomes that matter to patients Thevelin S, Spinewine A, Beuscart JB, Boland B, Marien S, Vaillant F, Wilting I, Vondeling A, Floriani C, Schneider C, Donzé J, Rodondi N, Cullinan S, O'Mahony D, Dalleur O.

Characterization of the effects of the budesonide-hydroxypropyl-β-cyclodextrin complex on lipid membranes and the cellular response to hydrogen peroxide and lipopolysaccharide Related publications : dos Santos AG*, Bay​iha JC*, Dufour G, Cataldo D, Evrard B, Silva LC, Deleu M, Mingeot-Leclercq M-P (2017) Changes in membrane biophysical properties induced by the Budesonide/Hydroxypropyl-β-

Imaging markers of response to targeted therapies in BRAFV600E melanoma Related publications : Acciardo S, Mignion L, Lacomblez E, Schoonjans C, Joudiou N, Gourgue F, Bouzin C, Baurain JF, Gallez B, Jordan BF. J Cell Mol Med. 2019 Dec 13. doi: 10.1111/jcmm.14890.

Elia Bozzato (Advanced Drug Delivery and Biomaterials research group (ADDB/LDRI)): “Dual-drug Nanomedicine Hydrogel For A Long-term Local Treatment Of Glioblastoma” Morgane Thibaut (Metabolism and Nutrition research group (MNUT/LDRI)): “Contribution of bile acids as microbial cometabolites in cancer cachexia” info: G. Muccioli 02.764.72.31 <giulio.muccioli@uclouvain.be>

Presentation of the new thesis projects Hafsa AMERAOUI (BPBL/LDRI): “Contribution to the study of oxysterols in inflammatory bowel diseases: from their quantification in patients to the study of their properties in vitro and in vivo.” Chantale FARAH (REMA/LDRI & MIRO/IREC): “Imaging metabolic plasticity in melanoma: relevance of combining metabolic modulators with BRAF or immune checkpoint

presentation of the new thesis projects - Chiara BRUSTENGA (CMFA/LDRI & FATH/IREC): “Disrupting LDH tetramerization site, small molecules approach as a new anticancer strategy.” Jérôme CONQ (REMA/LDRI & ADDB/LDRI): “Strategies for a transient opening of the blood brain barrier to increase the delivery of nanomedicines to glioblastoma.” Juliette LAGREULA (CLIP/LDRI & PMGK/LDRI): “O